drugset / Trial / NCT04124081

Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects

NCT04124081

Phase 1 Completed 12 enrolled Beijing Continent Pharmaceutical Co, Ltd.
NaSingle-groupOpen-labelBasic science

Summary

This study, by comparing the Hydronidone capsules and entecavir capsule in a single dose and steady-state dosing state of both the level of blood drug concentration, assess Hydronidone capsules and entecavir capsule for interaction。

Timeline

Start
2019-05-15
Primary completion
2019-06-15
Completion
2019-08-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Entecavir Small molecule
Subject Hydronidone Small molecule

Indications

No indication recorded.